Cargando…

Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study

Detalles Bibliográficos
Autor principal: Frank, Samuel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042393/
http://dx.doi.org/10.1186/1471-2377-11-18
_version_ 1782198540054822912
author Frank, Samuel
author_facet Frank, Samuel
author_sort Frank, Samuel
collection PubMed
description
format Text
id pubmed-3042393
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30423932011-02-22 Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study Frank, Samuel BMC Neurol Correction BioMed Central 2011-02-04 /pmc/articles/PMC3042393/ http://dx.doi.org/10.1186/1471-2377-11-18 Text en Copyright ©2011 Frank and Huntington Study Group/TETRA-HD Investigators; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Frank, Samuel
Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title_full Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title_fullStr Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title_full_unstemmed Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title_short Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
title_sort correction:tetrabenazine as anti-chorea therapy in huntington disease: an open-label continuation study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042393/
http://dx.doi.org/10.1186/1471-2377-11-18
work_keys_str_mv AT franksamuel correctiontetrabenazineasantichoreatherapyinhuntingtondiseaseanopenlabelcontinuationstudy